PATIENT-DERIVED XENOGRAFTS AS PRECLINICAL MODELS OF LOCALISED AND METASTATIC CASTRATE-RESISTANT PROSTATE CANCER

被引:0
|
作者
Lawrence, M. G. [1 ]
Taylor, R. A. [2 ]
Pook, D. W. [1 ,3 ]
Wang, H. [1 ]
Porter, L. H. [1 ]
Frydenberg, M. [1 ,4 ,5 ]
Kourambas, J. [4 ]
Appu, S. [4 ,5 ]
Poole, C. [4 ]
Beardsley, E. K. [1 ]
Iddawela, M. [1 ]
Pezaro, C. I. [1 ]
Ryan, A. [6 ]
Norden, S. [6 ]
Papargiris, M. [1 ]
Thorne, H. [7 ,8 ]
Sandhu, S. K. [9 ]
Risbridger, G. P. [1 ]
机构
[1] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia
[2] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia
[3] Monash Canc Ctr, Dept Oncol, Clayton, Vic, Australia
[4] Monash Med Ctr, Dept Urol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Surg, Clayton, Vic, Australia
[6] TissuPath, Melbourne, Vic, Australia
[7] Peter MacCallum Canc Ctr, kConFab, Melbourne, Vic, Australia
[8] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia
[9] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
113
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [1] Novel prostate cancer patient-derived xenograft models of bone metastatic castrate-resistant prostate cancer
    Jamieson, Christina
    Wu, Christina
    Strasner, Amy
    Woo, Jason R.
    Muldong, Michelle
    Jeong, Young B.
    Liss, Michael A.
    Raheem, Omer
    Yamaguchi, Tomonori
    Leu, Heather
    Marshall, Deborah
    Morris, Sheldon
    Cacalano, Nicholas A.
    Masuda, Koichi
    Jamieson, Catriona H. M.
    Kulidjian, Anna A.
    Kane, Christopher J.
    [J]. MOLECULAR CANCER RESEARCH, 2014, 12
  • [2] New patient-derived models of castrate-sensitive and castrate-resistant prostate cancer
    Lawrence, Mitchell
    Clouston, David
    Frydenberg, Mark
    Murphy, Declan G.
    Pezaro, Carmel Jo
    Pook, David William
    Thorne, Heather
    Sandhu, Shahneen Kaur
    Toivanen, Roxanne
    Taylor, Renea
    Risbridger, Gail
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer
    Porter, Laura H.
    Bakshi, Andrew
    Pook, David
    Clark, Ashlee
    Clouston, David
    Kourambas, John
    Goode, David L.
    Risbridger, Gail P.
    Taylor, Renea A.
    Lawrence, Mitchell G.
    [J]. JOURNAL OF PATHOLOGY, 2021, 254 (02): : 121 - 134
  • [4] Establishment of Primary Patient-Derived Xenografts of Palliative TURP Specimens to Study Castrate-Resistant Prostate Cancer
    Lawrence, Mitchell G.
    Pook, David W.
    Wang, Hong
    Porter, Laura H.
    Frydenberg, Mark
    Kourambas, John
    Appu, Sree
    Poole, Christine
    Beardsley, Emma K.
    Ryan, Andrew
    Norden, Sam
    Papargiris, Melissa M.
    Risbridger, Gail P.
    Taylor, Renea A.
    [J]. PROSTATE, 2015, 75 (13): : 1475 - 1483
  • [5] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [6] Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
    Risbridger, Gail P.
    Toivanen, Roxanne
    Taylor, Renea A.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (08):
  • [7] Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
    Risbridger, Gail P.
    Toivanen, Roxanne
    Taylor, Renea A.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [8] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    [J]. APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [9] Olaparib in metastatic castrate-resistant prostate cancer
    不详
    [J]. BJU INTERNATIONAL, 2020, 126 (02) : 235 - 235
  • [10] Preclinical models of prostate cancer: New patient-derived xenografts for preclinical studies and evaluation of prostate cancer biology
    Nguyen, Holly M.
    Morrissey, Colm
    Nelson, Peter S.
    Zhang, Xiaotun
    Lange, Paul H.
    Vessella, Robert L.
    Corey, Eva
    [J]. CANCER RESEARCH, 2014, 74 (19)